Comparison Between Activated Partial Thromboplastin Time and Anti-Xa Heparin Assays on Patients on Unfractionated Heparin Therapy

被引：0
|
作者：
Pearlman, Eugene [1 ]
Bibars, Wafi [2 ]
Willard, Jennifer [3 ]
Moore, Darlene [3 ]
机构：
[1] Vet Affairs Med Ctr, Memphis, TN USA
[2] Univ Tennessee, Hlth Sci Ctr, Knoxville, TN 37996 USA
[3] Vet Affairs Med Ctr Memphis, Memphis, TN USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2015年 / 144卷
关键词：
D O I：
10.1093/ajcp/144.suppl2.127
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
127
引用
收藏
页码：A127 / A127
页数：1
相关论文
共 50 条
  • [21] Comparison of bleeding complications between Anti-Xa and aPTT monitoring in patients receiving unfractionated heparin
    Belk, K. W.
    Laposata, M.
    Craver, C. W.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 213 - 213
  • [22] Activated Partial Thromboplastin Time Versus Antifactor Xa Heparin Assay in Monitoring Unfractionated Heparin by Continuous Intravenous Infusion
    Guervil, David J.
    Rosenberg, Amy F.
    Winterstein, Almut G.
    Harris, Neil S.
    Johns, Thomas E.
    Zumberg, Marc S.
    ANNALS OF PHARMACOTHERAPY, 2011, 45 (7-8) : 861 - 868
  • [23] Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations
    Marlar, Richard A.
    Clement, Bernadette
    Gausman, Jana
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (03): : 253 - 260
  • [24] Discordance between activated partial thromboplastin time and heparin level measured with anti-Xa assay in antithrombin-deficient plasma
    Yi, A. K.
    Stevic, I
    Gantioqui, J.
    Lau, K. K.
    Roberts, R.
    Chan, A. K.
    Chan, H. H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 803 - 803
  • [25] Comparison of anti-factor Xa heparin activity and activated partial thromboplastin time in 2,773 plasma samples from unfractionated heparin-treated patients
    Rosborough, TK
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 108 (06) : 662 - 668
  • [26] Evaluation of Anti-Xa and Activated Partial Thromboplastin Time Monitoring of Heparin in Adult Patients Receiving Extracorporeal Membrane Oxygenation Support
    Arnouk, Serena
    Altshuler, Diana
    Lewis, Tyler C.
    Merchan, Cristian
    Smith, Deane E., III
    Toy, Bridget
    Zakhary, Bishoy
    Papadopoulos, John
    ASAIO JOURNAL, 2020, 66 (03) : 300 - 306
  • [27] Effectiveness of a Calculation-Free Weight-Based Unfractionated Heparin Nomogram With Anti-Xa Level Monitoring Compared With Activated Partial Thromboplastin Time
    Kindelin, Nicole M.
    Anthes, Ananth M.
    Providence, Sarah M.
    Zhao, Xinhua
    Aspinall, Sherrie L.
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (05) : 575 - 583
  • [28] Activated Partial Thromboplastin Time versus Anti-Factor Xa Levels for Monitoring Unfractionated Heparin Therapy in Children: An Institutional Experience
    Woods, Gary M.
    Stanek, Joseph
    Harrison, Sheilah
    Texter, Karen
    Kerlin, Bryce A.
    Dunn, Amy L.
    Kumar, Riten
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (07) : 576 - +
  • [29] Clinical outcomes with unfractionated heparin monitored by anti-factor Xa vs. activated partial Thromboplastin time
    Coons, James C.
    Iasella, Carlo J.
    Thornberg, Megan
    Fitzmaurice, Mary Grace
    Goehring, Kimberly
    Jablonski, Lindsay
    Leader, Dominic
    Meyer, Abby
    Seo, Hangil
    Benedict, Neal J.
    Smith, Roy E.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (09) : 1015 - 1019
  • [30] Utilising a hybrid anti-Xa calibration assay in unfractionated heparin (UFH) monitoring: validation of assay and its correlation with activated partial thromboplastin time (aPTT)
    Lukito, Pohan
    Collecutt, Margaret
    Dauer, Raymond
    Morgan, Susan
    Huyen Tran
    PATHOLOGY, 2016, 48 (05) : 501 - 503
12345